Esomeprazole is a proton pump inhibitor that reduces the amount of acid in the stomach. The esomeprazole capsules are also approved to reduce the risk of gastric ulcers associated with use of non-steroidal anti-inflammatory drugs.
Ivax Pharmaceuticals, a subsidiary of Teva Pharmaceuticals USA, developed the capsules.
More articles on GI/endoscopy:
14 statistics on gastroenterologist burnout
GI physician leader to know: Dr. Peter Banks of Brigham and Women’s Hospital
Actavis to acquire Auden Mckenzie for approximately $460M